75291-16-6

Upstream product

• 1128085-99-3 1-(2-chlorophenyl)-4-(4-nitrophenyl)piperazine 

Downstream Products

• 87602-51-5 {4-[4-(2-Chloro-phenyl)-piperazin-1-yl]-phenyl}-(2,8-dimethyl-quinolin-4-yl)-amine 
• 1128086-10-1 6-chloro-N-{4-[4-(2-chlorophenyl)piperazin-1-yl]phenyl}nicotinamide 
• 1128086-01-0 N-{4-[4-(2-chlorophenyl)piperazin-1-yl]phenyl}carbamic acid ethyl ester 
• 1128086-06-5 N-{4-[4-(2-chlorophenyl)piperazin-1-yl]phenyl}acetamide 
• 87602-46-8 {4-[4-(2-Chloro-phenyl)-piperazin-1-yl]-phenyl}-(8-methoxy-2-methyl-quinolin-4-yl)-amine 
• 87602-47-9 (6-Chloro-2-methyl-quinolin-4-yl)-{4-[4-(2-chloro-phenyl)-piperazin-1-yl]-phenyl}-amine 
• 87602-52-6 {4-[4-(2-Chloro-phenyl)-piperazin-1-yl]-phenyl}-(2,6-dimethyl-quinolin-4-yl)-amine 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of new arylpiperazines N-{4-[4-(aryl) piperazine-1-yl]-phenyl}-amine derivatives: Putative role of 5-HT1A receptors

In an attempt to design novel 5-HT1A agonists/partial agonists, based on an arylpiperazine nucleus, a series of N-{4-[4-(aryl)piperazine-1-yl]-phenyl}-amine derivatives were synthesized and biologically tested. The anxiolytic effect of the comp